More on ACET
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.26 |
|
|||
| Open | $9.26 | ||||
| 52 Wk High | $28.54 | ||||
| 52 Wk Low | $15.69 | ||||
| Day High | $9.26 | ||||
| Day Low | $9.26 | ||||
| P/E | 8.34 | ||||
| EPS | $1.11 | ||||
| Volume | 192 | ||||
- FDA clears Adicet Bio IND application for prostate cancer therapy
- Adicet Bio Announces FDA Clearance of IND Application for ADI-212
- Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
- Form 4 Adicet Bio, Inc. For: Aug 05 Filed by: Klickstein Lloyd
- Adicet Bio Inc. (ACET) PT Lowered to $90 at Guggenheim
- Form 10-Q Adicet Bio, Inc. For: Jun 30
- Form 8-K Adicet Bio, Inc. For: Aug 05
- Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Lipocine names former Johnson & Johnson executive to its board
- Lipocine Appoints Michael J. Grissinger to Board of Directors
Entities mentioned with ACET
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
